XOMA. Bull or Bear? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear?

XOMA 25.54

+1.4%

Dec 15 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Lance Bredvold who wrote (15905)	7/17/2002 6:59:38 PM
From: LarryS	Read Replies (1) of 17367

About the BGEN thing. We never talked about BGEN until we became competitors in the psoriasis market. We are miffed because BGEN is about a year ahead of XOMA...and shouldn't be. BGEN's product will have safety problems that ours won't. And we were amazed that with its safety problems and its incredibly small number of trial subjects that BGEN's product was approved by the FDA committee. We thought the FDA would ask for more data...Cacaito thought it would be approved and was right. It didn't help when a couple of BGEN pumpers then hit our Yahoo board gloating about their victory...check out posts by gollywhatazoo. It is not a serious problem, just a couple of competitors hitting each other with wiffle bats.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next